Ortho-McNeil Pharmaceutical

Ortho-McNeil To Acquire U.S. Rights To AXERT

Ortho-McNeil Pharmaceutical, Inc. is to acquire the U.S. sales and marketing rights to AXERT (almotriptan malate) Tablets, pursuant to a licensing agreement with the drug’s innovator Almirall. AXERT is a prescription medication approved to treat migraine headaches in adults. Completion of the transaction, which is expected to occur during the second quarter of 2003, is Read more about Ortho-McNeil To Acquire U.S. Rights To AXERT[…]

New Treatment Option Approved For Lennox-Gastaut Syndrome

The U.S. FDA has approved Topamax (topiramate) tablets and sprinkle capsules as an adjunctive (add-on) treatment for adults and children (age 2-16) suffering from seizures associated with Lennox-Gastaut Syndrome (LGS) is one of the most severe forms of epilepsy. Individuals who suffer from this illness experience dozens of seizures a day, many of which are Read more about New Treatment Option Approved For Lennox-Gastaut Syndrome[…]